Ruf S, Baltromejus S, Pancherz H
Department of Orthodontics, University of Giessen, Germany.
Angle Orthod. 2001 Feb;71(1):4-11. doi: 10.1043/0003-3219(2001)071<0004:ECGACP>2.0.CO;2.
Effective condylar growth (a summation of condylar remodeling, glenoid fossa remodeling, and condylar position changes within the fossa) and its influence on the position of the chin was analyzed in 40 class II, division I malocclusions treated successfully with activators. Additionally, the amount of mandibular rotation was assessed. Lateral head films in habitual occlusion from before and after an average treatment period of 2.6 years were evaluated. The Bolton Standards (32 untreated individuals with ideal occlusion) served as controls. Two different treatment effects were evaluated: overall growth change and treatment effects (overall growth changes minus age-related Bolton values). In comparison with the Bolton group, the activator patients exhibited an increase in the amount of vertical effective condylar growth (3.0 mm; P < .001), a decrease in the amount of sagittal effective condylar growth (0.6 mm; P < .05), and an increase in the amount of vertical development of the chin (1.8 mm; P < .001). No group differences could be found for sagittal development of the chin. In the Bolton group, the mandible rotated posteriorly, and in the activator group it rotated anteriorly (2.7 degrees; P < .001). The present investigation revealed that effective condylar growth can be increased and the chin position can be changed by activator treatment. Thus activator treatment induces skeletal changes, although not always in the desired (sagittal) therapeutic direction.
对40例使用肌激动器成功治疗的安氏II类1分类错牙合患者,分析了髁突有效生长(髁突改建、关节窝改建以及髁突在关节窝内位置变化的总和)及其对颏部位置的影响。此外,评估了下颌旋转量。对平均2.6年治疗期前后习惯性咬合状态下的头颅侧位片进行了评估。以Bolton标准(32例未经治疗的理想咬合个体)作为对照。评估了两种不同的治疗效果:整体生长变化和治疗效果(整体生长变化减去与年龄相关的Bolton值)。与Bolton组相比,使用肌激动器的患者垂直方向髁突有效生长量增加(3.0 mm;P <.001),矢状方向髁突有效生长量减少(0.6 mm;P <.05),颏部垂直发育量增加(1.8 mm;P <.001)。颏部矢状向发育在两组间未发现差异。在Bolton组中,下颌向后旋转,而在肌激动器组中,下颌向前旋转(2.7度;P <.001)。本研究表明,肌激动器治疗可增加髁突有效生长并改变颏部位置。因此,肌激动器治疗可引起骨骼改变,尽管并不总是朝着期望的(矢状向)治疗方向发展。